Claim · 2024-05-08 · publication · Stated in source · Supported

The 8 May 2024 post introduces AlphaFold 3 as "a new AI model developed by Google DeepMind and Isomorphic Labs".

One recorded claim. The claim panel gives its qualification, the source passages with their place in each source, and how it was checked.

What it connects

AlphaFold 3 predicts the structure and interactions of all of life's molecules → states provision → AlphaFold 3 stated as developed by Google DeepMind and Isomorphic Labs

Where it appears

No collection page holds this claim. It is listed with its records in the explorer.

Claim and evidence

AlphaFold 3 predicts the structure and interactions of all of life's moleculesstates provision ↓AlphaFold 3 stated as developed by Google DeepMind and Isomorphic Labs

Machine-checked, not reviewed by an editorStated in sourceSupported

Supporting evidence: primary · 1 source; Context: primary · 1 source

Provision: Statement · provision ID labs-gdm-af3-joint-2024
Date: 2024-05-08 · publication Records dated 2024 →

Scope and limitsJoint development as the developers state it; the paper's credited authorship is recorded by the models and people passes. Isomorphic Labs' March 2025 release also states that AlphaFold 3 was developed and released in May 2024 by Isomorphic Labs together with Google DeepMind (context).

The evidence 02

primary sourceSupports the claim

AlphaFold 3 predicts the structure and interactions of all of life's molecules

Google (The Keyword blog; post credited to the Google DeepMind AlphaFold team and Isomorphic Labs) · 2024-05-08

Cite the original source

Cite the original document, not Selekoa. Check these details against it.

Source excerpt

“Introducing AlphaFold 3, a new AI model developed by Google DeepMind and Isomorphic Labs.”

Location in source standfirst

How it was read Retrieved directly from the publisher

Machine-checked · 2026-10-30

Source details and check notes

Authors: Google DeepMind AlphaFold team; Isomorphic Labs
Version: Retrieved for the candidate pack on 2026-10-30 (SHA-256 b13b481c0b795e95a74e351035d5270048d596b4bf58195655d9222d09238643). blog.google post dated May 08, 2024, as served on 2026-10-30 (the requested address redirected to /innovation-and-ai/products/…); it carries a later note above the "Original post". Its wording can change; earlier wording is not authenticated.
Canonical address: Open the canonical source ↗
Accessed: 2026-10-30
Language: English (en)
Attribution: Google DeepMind AlphaFold team, Isomorphic Labs, “AlphaFold 3 predicts the structure and interactions of all of life's molecules”, 2024-05-08.
Reuse: No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution.
Check notes: Candidate pack passage, AI in biology (research/ai-in-biology). The quotation (14 words) matched the text retrieved for the candidate pack on 2026-10-30. Matching ignored differences of whitespace, case, quotation marks, dashes and Unicode compatibility forms, so the source’s typography can differ. No human editorial review.

primary sourceContext only

Isomorphic Labs announces $600 million funding to further develop its next-generation AI drug design engine and advance therapeutic programs into the clinic

Isomorphic Labs · 2025-03-31

Cite the original source

Cite the original document, not Selekoa. Check these details against it.

Source excerpt

“AlphaFold 3, developed and released in May 2024 by Isomorphic Labs together with Google DeepMind”

Location in source PDF p. 1, fourth paragraph

How it was read Retrieved directly from the publisher

Machine-checked · 2026-10-30

Source details and check notes

Authors: Isomorphic Labs
Version: Retrieved for the candidate pack on 2026-10-30 (SHA-256 e951f4f8ee6b24076c8112db8ee5eed3cb594218cc837305557e240389e43ac8). PDF news release dated LONDON, 31 March, 2025, linked from the Isomorphic Labs article of that date; retrieved 2026-10-30. Its wording can change; earlier wording is not authenticated.
Canonical address: Open the canonical source ↗
Accessed: 2026-10-30
Language: English (en)
Attribution: Isomorphic Labs, “Isomorphic Labs announces $600 million funding to further develop its next-generation AI drug design engine and advance therapeutic programs into the clinic”, 2025-03-31.
Reuse: No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution.
Check notes: Candidate pack passage, AI in biology (research/ai-in-biology). The quotation (15 words) matched the text retrieved for the candidate pack on 2026-10-30. Matching ignored differences of whitespace, case, quotation marks, dashes and Unicode compatibility forms, so the source’s typography can differ. No human editorial review.

Status and meaning

Editorial status. Not reviewed by an editor. An exploratory record that no editor has accepted. This status does not say whether a person has read any linked passage. Each evidence record above shows how it was checked.

Relation. An exact framework edition, or another document with an exact expression, states one provision: a capability threshold or risk level and its trigger, a required safeguard or action, a decision authority (who decides, recommends, can overrule or is informed), a stated exception, or another statement of its content, such as a licence term or a prospectus statement. The passage records what the document says, not implementation, compliance or effectiveness. Provisions with the same key align across editions of one family.

Date. Dated by the post. The record is dated by the text’s date of publication, which is the date of its announcement.

Record ID aib-labs-gdm-af3-joint-2024